EpiPose aims to provide urgently needed answers about the epidemiological characteristics of 2019-nCoV, the socialdynamics of the outbreak, and the related public health preparedness and response to the ongoing epidemic, as wellas to assess its economic impact.
The consortium consists of 6 partners in 5 countries (BE, NL, UK, CH, IT) whoprovide complementary expertise in mathematical and statistical modelling of infectious diseases, participatorysurveillance systems, living systematic reviews, and health economic analysis and have a strong international publichealth network.
EpiPose aims at a quick delivery of results, according to the following objectives:
(1) To collect andshare epidemiological data of 2019-nCoV as widely as possible
(2) To provide country-specific estimates of keyepidemiological parameters
(3) To model the expect impact of 2019-nCoV on morbidity and mortality
(4) To monitorawareness and behavioural change during the 2019-nCoV epidemic
(5) To provide health economic analyses forinterventions within the EU
(6) To foster the interaction between the scientific community, public health agencies andthe public EpiPose aims to make all research data, code, tools and results publicly available and its dissemination plantargets active communication and interaction with policy makers, other scientific groups and the general public. Assuch, the epidemic intelligence provided by EpiPose will help minimize the 2019-nCoV’s public health, economic andsocial impact.